The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Trazodone Hydrochloride Azure 100 mg Hard Capsules

Azure Pharmaceuticals LtdPA22871/018/002

Main Information

Trade NameTrazodone Hydrochloride Azure 100 mg Hard Capsules
Dosage FormCapsule, hard
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/018/002

Group Information

ATC CodeN06AX05 trazodone


License statusAuthorised
Licence Issued30/09/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back